Kết quả tìm kiếm - Eric D. Jacobsen
- Đang hiển thị 1 - 20 kết quả của 56
- Chuyển đến trang tiếp theo
-
1
Follicular lymphoma: 2023 update on diagnosis and management Bằng Eric D. Jacobsen
Được phát hành 2022Artigo -
2
Follicular lymphoma: 2020 update on diagnosis and management Bằng Arnold S. Freedman, Eric D. Jacobsen
Được phát hành 2019Revisão -
3
-
4
-
5
-
6
Increased Risk of Infectious Complications in Older Patients With Indolent Non-Hodgkin Lymphoma Exposed to Bendamustine Bằng Monica Fung, Eric D. Jacobsen, Arnold S. Freedman, Daniel Prestes, Dimitrios Farmakiotis, Xiangmei Gu, Paul L. Nguyen, Sophia Koo
Được phát hành 2018Artigo -
7
-
8
Phase II trial of oral vorinostat (suberoylanilide hydroxamic acid) in relapsed diffuse large-B-cell lymphoma Bằng Michael Crump, Bertrand Coiffier, Eric D. Jacobsen, Linda Sun, Justin L. Ricker, Huafeng Xie, Stanley R. Frankel, Sophia Randolph, Bruce D. Cheson
Được phát hành 2008Artigo -
9
-
10
A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoides/Sezary syndrome Bằng Eric D. Jacobsen, H. T. Kim, Vincent T. Ho, Corey Cutler, John Koreth, David C. Fisher, Philippe Armand, Edwin P. Alyea, Arnold S. Freedman, RJ Soiffer, Joseph H. Antin
Được phát hành 2011Artigo -
11
Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimul... Bằng John F. DiPersio, Ivana N. Micallef, Patrick J. Stiff, Brian J. Bolwell, Richard T. Maziarz, Eric D. Jacobsen, Auayporn Nademanee, John M. McCarty, Gary Bridger, Gary Calandra
Được phát hành 2009Artigo -
12
Response to Brentuximab Vedotin by CD30 Expression in Non-Hodgkin Lymphoma Bằng Deepa Jagadeesh, Steve Horwitz, Nancy L. Bartlett, Hyun Soo Kim, Eric D. Jacobsen, Madeleine Duvic, Meredith Little, William L. Trepicchio, Keenan Fenton, Matthew Onsum, Julie Lisano, Ranjana H. Advani
Được phát hành 2022Artigo -
13
Prognostic factors for patients with diffuse large <scp>B</scp> cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation in the positron emis... Bằng Philippe Armand, Sarah A. Welch, Haesook T. Kim, Ann S. LaCasce, Eric D. Jacobsen, Matthew S. Davids, Caron A. Jacobson, David C. Fisher, Jennifer R. Brown, Erin Coughlin, Arnold S. Freedman, Yi‐Bin Chen
Được phát hành 2012Artigo -
14
Everolimus in combination with rituximab induces complete responses in heavily pretreated diffuse large B-cell lymphoma Bằng Jeffrey A. Barnes, Eric D. Jacobsen, Yang Feng, AS Freedman, Ephraim P. Hochberg, Ann S. LaCasce, Philippe Armand, Robin Joyce, Aliyah R. Sohani, Scott J. Rodig, Donna Neuberg, David C. Fisher, Jeremy S. Abramson
Được phát hành 2012Artigo -
15
Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expression Bằng Eric D. Jacobsen, Jeff P. Sharman, Yasuhiro Oki, Ranjana H. Advani, Jane N. Winter, Celeste M. Bello, Gary Spitzer, Maria Corinna Palanca-Wessels, Dana A. Kennedy, Pamela Levine, Jing Yang, Nancy L. Bartlett
Được phát hành 2015Artigo -
16
Ventricular arrhythmias and sudden death in patients taking ibrutinib Bằng Benjamin L. Lampson, Lijian Yu, Robert J. Glynn, Jacqueline C. Barrientos, Eric D. Jacobsen, Versha Banerji, Jeffrey A. Jones, Renata Walewska, Kerry J. Savage, Gregory F. Michaud, Javid J. Moslehi, Jennifer R. Brown
Được phát hành 2017Carta -
17
A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma Bằng Thomas E. Witzig, Craig B. Reeder, Betsy LaPlant, Mamta Gupta, Patrick B. Johnston, Ivana N. Micallef, Luis F. Porrata, Stephen M. Ansell, Joseph P. Colgan, Eric D. Jacobsen, Irene M. Ghobrial, Thomas M. Habermann
Được phát hành 2010Artigo -
18
Allogeneic Transplantation with Reduced-Intensity Conditioning for Hodgkin and non-Hodgkin Lymphoma: Importance of Histology for Outcome Bằng Philippe Armand, Haesook T. Kim, Vincent T. Ho, Corey Cutler, John Koreth, Joseph H. Antin, Ann S. LaCasce, Eric D. Jacobsen, David C. Fisher, Jennifer R. Brown, George P. Canellos, Arnold S. Freedman, Robert J. Soiffer, Edwin P. Alyea
Được phát hành 2008Artigo -
19
Phase II Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia Bằng Philip C. Amrein, Eyal C. Attar, Tak Takvorian, Ephraim P. Hochberg, Karen K. Ballen, K. Leahy, David C. Fisher, Ann S. LaCasce, Eric D. Jacobsen, Philippe Armand, Robert P. Hasserjian, Lillian Werner, Donna Neuberg, Jennifer R. Brown
Được phát hành 2011Artigo -
20
A phase 2 study of Rituximab‐Bendamustine and Rituximab‐Cytarabine for transplant‐eligible patients with mantle cell lymphoma Bằng Philippe Armand, Robert Redd, Jad Bsat, Sangeetha Mayuram, Angela Giardino, David C. Fisher, Ann S. LaCasce, Caron A. Jacobson, Matthew S. Davids, Jennifer R. Brown, Li Weng, Jennifer Wilkins, Malek Faham, Arnold S. Freedman, Robin Joyce, Eric D. Jacobsen
Được phát hành 2016Artigo
Công cụ tìm kiếm:
Các môn học liên quan
Medicine
Internal medicine
Lymphoma
Oncology
Chemotherapy
Gastroenterology
Immunology
Biology
Surgery
Clinical trial
Transplantation
Cancer
Neutropenia
Pathology
Refractory (planetary science)
Astrobiology
Cancer research
Immune system
Adverse effect
Phases of clinical research
T cell
Autologous stem-cell transplantation
Clinical endpoint
Disease
Rituximab
Brentuximab vedotin
Peripheral T-cell lymphoma
Physics
Diffuse large B-cell lymphoma
Genetics